Neuromodulation for Obsessive–Compulsive Disorder
نویسندگان
چکیده
منابع مشابه
Neuromodulation for treatment-refractory major depressive disorder.
ajor depressive disorder is among the most prevalent psychiatric disorders and is a leading cause of morbidity and lost productivity. 1 The 1-year prevalence of major depressive disorder in the Canadian population is 3.2%–4.6%. 2 A large, multisite prospective trial showed that only 28% of patients ex-peri ence remission following monotherapy with a serotonin reuptake inhibitor. 3 Further, remi...
متن کاملObsessivecompulsive symptoms with olanzapine
The emergence or exacerbation of obsessive– compulsive (OC) symptoms during treatment with atypical antipsychotics, mostly clozapine, has been documented by numerous case reports (reviewed by Lykouras et al., 2003). In six recent reports involving nine cases, (Jonkers and deHaan, 2002; Lykouras et al., 2003) olanzapine was found either to cause de novo emergence or to exacerbate OC symptoms. In...
متن کاملObsessivecompulsive disorder and traumatic brain injury: behavioral, cognitive, and neuroimaging findings.
OBJECTIVE The goal of this study was to evaluate behavior and cognition in a consecutive series of patients who developed obsessive-compulsive disorder (OCD) after suffering a traumatic brain injury (TBI). BACKGROUND Because OCD is a rare sequelae of TBI, the phenomenology of obsessions and compulsions, the comorbid psychiatric disorders, the performance on cognitive tests, and the neural cor...
متن کاملExpanding indications for neuromodulation.
Neuromodulation in one form or another has been studied for decades for various disease states. Although its mechanism of action remains un-explained, numerous clinical success stories suggest it is a therapy with efficacy and durability. Controlled studies have led to the approval of sacral neuromodulation for urinary urgency and frequency, urinary retention, and urinary urge incontinence. The...
متن کاملNew Technologies for Neuromodulation
Non-invasive neural stimulation techniques are of increasing importance as devices move from the lab to the clinical environment. One such technology-transcranial magnetic stimulation-has already made the transition and is currently used by clinicians to treat depression. This device has several drawbacks, such as a limited ability to focus its energy to a relatively small region and to distrib...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurotherapeutics
سال: 2014
ISSN: 1933-7213,1878-7479
DOI: 10.1007/s13311-014-0287-9